Toggle Main Menu Toggle Search

Open Access padlockePrints

Trends in, and predictors of, swallowing and social eating outcomes in head and neck cancer survivors: A longitudinal analysis of head and neck 5000

Lookup NU author(s): Dr Liya Lu, Professor Linda Sharp

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2021Objective: To investigate the recovery trajectory and predictors of outcome for swallowing difficulties following head and neck cancer treatment in a large prospective cohort. Materials and methods: Data from 5404 participants of the Head and Neck 5000 study were collected from 2011 to 2014. Patient-reported swallowing was measured using the EORTC HN35, recorded at baseline (pre-treatment) and 4 and 12 months post-baseline. Mixed-effects linear multivariable regression was used to investigate time trends, compare cancer sites, and identify associations between clinical, socio-demographic and lifestyle variables. Results: 2458 participants with non-recurrent oral (29%) oropharyngeal (46%) and laryngeal (25%) cancer were included in the analysis. There was a clinically significant deterioration in scores between baseline and four months for swallowing (11.7 points; 95% CI 10.7–12.8) and trouble with social eating (17.9 points; 95% CI 16.7–19.2), but minimal difference between baseline and 12 months. Predictors of better swallowing and social eating were participants with larynx cancer, early-stage disease, treatment type, age, gender, co-morbidity, socio-economic status, smoking behaviour and cohabitation. Conclusion: Swallowing problems persist up to a year after head and neck cancer treatment. These findings identify disease and demographic characteristics for particularly vulnerable groups, supporting the need for holistic interventions to help improve swallowing outcomes. People diagnosed with head and neck cancer at risk of severe eating and drinking problems following treatment can be identified earlier in the pathway, receive more accurate information about early and late post-treatment side-effects, which can inform shared decision-making discussions.


Publication metadata

Author(s): Patterson JM, Lu L, Watson L-J, Harding S, Ness AR, Thomas S, Waylen A, Waterboer T, Sharp L

Publication type: Article

Publication status: Published

Journal: Oral Oncology

Year: 2021

Volume: 118

Print publication date: 01/07/2021

Online publication date: 20/05/2021

Acceptance date: 08/05/2021

ISSN (print): 1368-8375

ISSN (electronic): 1879-0593

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/j.oraloncology.2021.105344

DOI: 10.1016/j.oraloncology.2021.105344

PubMed id: 34023744


Altmetrics

Altmetrics provided by Altmetric


Share